GLP-3 refers to the emerging class of triple-receptor agonist peptides that simultaneously target GLP-1, GIP, and glucagon receptors. These multi-agonist compounds, led by Retatrutide (LY3437943), represent a significant advancement in metabolic research beyond single or dual agonists. Researchers are actively studying their effects on energy balance, glucose regulation, and body composition signaling pathways in preclinical and laboratory models.
Definition: GLP-3 category peptides are synthetic molecules engineered to activate three key receptors (GLP-1R, GIPR, and glucagon receptor) in a single compound. They are used exclusively in laboratory research to investigate multi-pathway metabolic signaling. All products are for research use only and not for human administration.
This guide is intended for licensed researchers, academic investigators, and laboratory procurement professionals evaluating GLP-3 compounds such as Retatrutide for preclinical studies. All compounds discussed are strictly for research use only (RUO).
What Is GLP-3 and How Does It Compare to GLP-1 and GLP-2 Agonists?
GLP-3 represents the next evolution in incretin-based research tools. While traditional GLP-1 agonists target one receptor and dual agonists (often referred to in research contexts as GLP-2 category, such as Tirzepatide) engage two, GLP-3 compounds like Retatrutide activate three distinct receptors simultaneously: GLP-1, GIP, and glucagon.
This triple approach allows labs to study complex receptor cross-talk and synergistic signaling that single or dual agents cannot replicate. For researchers exploring advanced metabolic models, Retatrutide is the primary GLP-3 compound available at research-grade purity.
In plain terms for the lab: GLP-3 isn’t just “more of the same.” The added glucagon receptor activity introduces new dimensions to energy expenditure and lipid metabolism studies that dual agonists like Tirzepatide (GLP-2 category) do not fully capture.
Mechanism of Action: Triple Receptor Engagement
Retatrutide (the flagship GLP-3 research peptide) is a 39-amino-acid synthetic peptide designed for balanced potency across three receptors. In laboratory settings, it enables investigation of:
- GLP-1 receptor: Glucose-dependent insulin signaling and appetite regulation pathways
- GIP receptor: Complementary effects on insulin secretion and lipid metabolism
- Glucagon receptor: Hepatic glucose output, energy expenditure, and lipolysis pathways
This balanced triple agonism creates unique intracellular signaling networks. Preclinical models show potential for studying amplified effects on body weight regulation and metabolic parameters beyond what is observed with dual agonists.
Researchers particularly value GLP-3 tools for comparative studies against Tirzepatide (GLP-2 category) to isolate the contribution of glucagon receptor activation.
Key Research Applications for GLP-3 Compounds
Laboratories are using GLP-3 peptides such as Retatrutide in several high-priority areas:
- Multi-receptor signaling and cross-talk studies
- Metabolic regulation and energy expenditure models
- Comparative pharmacology vs. single/dual agonists
- Body composition and lipid metabolism research
- In vitro and ex vivo receptor binding and functional assays
The ability to engage all three receptors in one molecule makes GLP-3 compounds powerful tools for dissecting integrated metabolic responses in controlled laboratory environments.
Molecular Characteristics and Technical Specifications
High-quality research requires precise data. Retatrutide (GLP-3) characteristics include:
| Property | Value / Description |
|---|---|
| Compound | Retatrutide (LY3437943) |
| Category | Triple GLP-1/GIP/Glucagon Receptor Agonist (GLP-3) |
| Amino Acid Length | 39 |
| Purity Standard | ≥99% (HPLC verified) |
| Testing | Independent third-party HPLC + LC-MS/MS |
| Form | Synthetic lyophilized powder |
| Intended Use | In vitro and preclinical laboratory research only |
Full specifications and lot-specific data are available on the Retatrutide product page.
GLP-3 vs GLP-2 (Tirzepatide) vs GLP-1 Agonists: Side-by-Side Comparison
Understanding the differences helps labs select the right tool for their experimental goals.
| Feature | GLP-1 Agonists | GLP-2 (e.g. Tirzepatide) | GLP-3 (e.g. Retatrutide) |
|---|---|---|---|
| Receptors Targeted | GLP-1R | GLP-1R + GIPR | GLP-1R + GIPR + Glucagon R |
| Research Focus | Insulin secretion pathways | Dual incretin signaling | Triple pathway synergy & energy expenditure |
| Key Differentiation | Single pathway | Enhanced insulin + lipid effects | Added glucagon-mediated effects |
| Available at Peptide.Express | No | Yes (Tirzepatide) | Yes (Retatrutide) |
Such comparisons are common in metabolic research programs exploring incremental benefits of multi-agonism.
Reconstitution and Laboratory Handling Protocols
Proper handling ensures experimental reproducibility. Follow these standard practices for lyophilized GLP-3 peptides:
- Allow vial to reach room temperature before opening.
- Reconstitute with sterile bacteriostatic water or appropriate research buffer.
- Gently swirl or vortex; avoid vigorous shaking.
- Aliquot immediately into single-use volumes.
- Store lyophilized at -20°C or below; reconstituted aliquots at -80°C for long-term.
Detailed step-by-step instructions are available in our peptide reconstitution guide. Use our dosing calculator tool for planning research workflows.
Quality Assurance Standards for GLP-3 Research Peptides
At Peptide.Express we maintain rigorous standards:
- ≥99% purity by reverse-phase HPLC
- LC-MS/MS identity confirmation
- Lot-specific Certificates of Analysis
- Third-party independent laboratory testing
- Endotoxin testing where appropriate for in vivo models
View our quality standards and lab results for transparency. Every order includes the CoA for your records.
Why Researchers Choose Peptide.Express for GLP-3 Studies
Our commitment includes fast US shipping, cold-chain packaging, competitive research pricing, and full documentation. Whether you need Retatrutide for triple-agonist studies or Tirzepatide for dual-agonist comparisons, we support legitimate laboratory research with traceable, high-purity materials.
Frequently Asked Questions
What is GLP-3 in research contexts?
GLP-3 is the category term for triple-receptor agonists like Retatrutide that target GLP-1, GIP, and glucagon receptors. It is used exclusively in laboratory research to study advanced metabolic signaling.
How does GLP-3 (Retatrutide) differ from GLP-2 (Tirzepatide)?
GLP-3 adds glucagon receptor activation on top of the GLP-1/GIP activity found in GLP-2 compounds like Tirzepatide. This enables research into broader energy expenditure and lipid pathways.
Is Retatrutide available for laboratory research?
Yes. High-purity Retatrutide (GLP-3) is available through qualified research suppliers like Peptide.Express with full analytical documentation.
What purity is required for GLP-3 research?
Most peer-reviewed studies use ≥98–99% purity confirmed by HPLC and mass spectrometry. All our batches meet or exceed this standard.
How should GLP-3 peptides be stored?
Lyophilized powder should be kept frozen. Reconstituted solutions should be aliquoted and stored at ultra-low temperatures to preserve integrity.
Can I use GLP-3 peptides for human or therapeutic purposes?
No. All GLP-3 compounds including Retatrutide are strictly for laboratory research use only and are not approved for any other purpose.
References
- Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, Nielsen OV. GLP-1 and other proglucagon-derived peptides are released from the gut in response to nutrient ingestion. Journal of Clinical Investigation. 1989;83(2):408-411. doi:10.1172/JCI113896.
- Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Endocrinology. 1990;126(5):2687-2691. doi:10.1210/endo-126-5-2687.
- Holst JJ. The physiology of glucagon-like peptide 1. Physiological Reviews. 2007;87(4):1409-1439. (Broader proglucagon family review).
- Additional peer-reviewed studies on proglucagon-derived peptides and gut hormone co-secretion (2010–2025 incretin biology reviews).
All references are from peer-reviewed scientific literature. Full-text access may require institutional login or purchase. Peptide.Express does not provide compounds for human use.
Research Use Only. This content is for educational and informational purposes regarding laboratory research. Always consult your institutional guidelines and use compounds only within approved protocols. Last updated: July 2026.
Explore more: Research Library • Full Catalog • Quality & Testing • Retatrutide Comparisons